9:22 AM
Leo Group India
| ||
| Onyx Pharmaceuticals' Shorts Appear Focused on Upcoming Review Reuters Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is a ~3 billion dollar pharmaceutical company which has improved its prospects dramatically in the last two years ... See all stories on this topic » | ||
| US top court rules for Glaxo on overtime pay Reuters That decision conflicted with an earlier ruling by the 2nd U.S. Circuit Court of Appeals in New York that pharmaceutical sales representatives qualified for ... See all stories on this topic » | ||
| FDA staff focus on Onyx cancer drug's side effects Reuters WASHINGTON (Reuters) - U.S. drug reviewers said the serious heart, lung and liver side effects of Onyx Pharmaceuticals Inc's carfilzomib drug may outweigh ... See all stories on this topic » | ||
| High court says no OT pay for drug sales reps The Seattle Times The Supreme Court has ruled that sales representatives for pharmaceutical companies do not qualify for overtime pay under federal law, a big victory for the ... See all stories on this topic » | ||
| Drug export up 27% at Rs 60000 crore in FY 12 Economic Times India 's exports of drugs, pharmaceutical & fine chemicals grew 27% to Rs 60000 crore for the year ended March 2012, according to data compiled by ... See all stories on this topic » | ||
| Pharmaceutical industry says HSE not funding cost-effective ... RTE.ie The organisation representing the pharmaceutical industry has claimed that patients are not getting access to new medicines. See all stories on this topic » | ||
| Supreme Court Rejects Overtime Pay for Drug Reps Fox Business The Pharmaceutical Research and Manufacturers of America, the drug industry's main trade group, had warned in a court brief that classifying sales ... See all stories on this topic » | ||
| Debiopharm and Ascepion Pharmaceuticals, Inc. Announce ... Business Review India (press release) LAUSANNE, Switzerland, and SUZHOU, China, June 18, 2012 /PRNewswire-Asia/ -- Debiopharm Group™ (Debiopharm), a global biopharmaceutical ... See all stories on this topic » | ||
| Raptor Pharmaceutical Completes Enrollment in Phase 2/3 Clinical ... MarketWatch (press release) NOVATO, Calif., Jun 18, 2012 (GlobeNewswire via COMTEX) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTP) , today announced ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment